Irritable Bowel Syndrome (IBS) Treatment With H1-receptor Antagonists

NCT01144832 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: ebastine
DRUG: placebo capsule

Sponsor

KU Leuven